|1.||Kleinman, Hynda K: 6 articles (04/2010 - 01/2003)|
|2.||Smart, Nicola: 4 articles (08/2014 - 01/2007)|
|3.||Sosne, Gabriel: 4 articles (10/2012 - 02/2002)|
|4.||Philp, Deborah: 4 articles (04/2010 - 01/2003)|
|5.||Goldstein, Allan L: 4 articles (09/2007 - 01/2003)|
|6.||Crockford, David: 3 articles (10/2012 - 09/2007)|
|7.||Riley, Paul R: 3 articles (01/2012 - 01/2007)|
|8.||Hannappel, E: 3 articles (04/2010 - 03/2001)|
|9.||Cha, Hee-Jae: 3 articles (01/2010 - 11/2003)|
|10.||Rubin, Bruce K: 3 articles (09/2007 - 11/2006)|
|1.||Wounds and Injuries (Trauma)
09/01/2007 - "Recent studies in wounds that had been artificially induced on normal skin, both in rodents and in human volunteers, have suggested that thymosin beta4 may be effective in promoting epithelial migration across the wounds. "
04/01/2010 - "Studies in various animal models of disease and repair with thymosin beta(4) (Tbeta(4)), the major actin-sequestering molecule in mammalian cells, have provided the scientific foundation for the ongoing dermal, corneal, and cardiac wound repair multicenter clinical trials. "
01/01/2003 - "These studies show that thymosin beta 4 is active for wound repair in models of impaired healing and may have efficacy in chronic wounds in humans."
09/01/1999 - "In this study, we investigated whether the angiogenic thymic peptide thymosin beta4 (Tbeta4) enhanced wound healing in a rat full thickness wound model. "
04/01/2010 - "Incisional wounds in rats treated locally with thymosin beta4 (Tbeta4) healed with minimal scaring and without loss in wound breaking strength. "
04/01/2010 - "Thymosin beta4: a key factor for protective effects of eEPCs in acute and chronic ischemia."
04/01/2010 - "In conclusion, eEPCs are capable of acute and chronic ischemia protection in a thymosin beta4 dependent manner."
02/01/2015 - "Controlled release of thymosin beta 4 using a collagen-chitosan sponge scaffold augments cutaneous wound healing and increases angiogenesis in diabetic rats with hindlimb ischemia."
02/01/2015 - "This study investigates the possible use of a collagen-chitosan sponge scaffold encapsulated with thymosin beta 4 (CCSS-eTβ4), an angiogenic factor, to accelerate cutaneous wound healing in streptozotocin (STZ)-induced diabetic rats with hindlimb ischemia. "
|5.||Type 2 Diabetes Mellitus (MODY)
|3.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|4.||Actins (F Actin)
|8.||Angiogenesis Inducing Agents (Angiogenesis Factor)